Question special

Pancreatic Cancer has a high rate of thromboembolism among the solid tumors. As such, a higher prevalence of Pancreatic Cancer in the study population should result in higher DVT/PE rates, and make the intervention easier to be studied with a lesser number of patients. Was this a factor during patient enrollment?